510(k) Report

510(k) · Cleared

Cleared

Biopince Ultra Full Core Biopsy Instrument

K101832510(k) TraditionalCleared Aug 27, 201057-day reviewClass II21 CFR 876.1075

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Medical Device Technologies, Inc. · KNW Instrument, Biopsy

Cleared on Aug 27, 2010 as substantially equivalent to K904987 (Vibronics, 1991) and 3 other predicates after a 57-day review. Its family tree reaches back 4 generations to 1987. 1 later device descends from it.

Decided
Aug 27, 2010
Review
57 days
Class
Class II
Product code
KNW
Recalls
None
Predicates
4

Its longest line of descent runs back 4 generations to K871390 (1987). 9 ancestors in all. 1 later device descends from it, 1 citing it directly.

Other ancestors, by year clearedDescendants, by year cleared 2005: 1 other ancestor2004: 2 other ancestors1991: 1 other ancestor1992: 1 other ancestor2011: 1 descendant clearedK871390 · Bard Biopty Biopsy System · C.R. Bard, Inc. · 1987K962969 · Medical Device Technologies, Inc.Ultra · Medical Device Technologies, Inc. · 1996×2: 2 generations cleared close together, K982085 (1998), K982960 (1998) 1990200020102020
  1. Root · 4 generations backK871390 Bard Biopty Biopsy SystemC.R. Bard, Inc. · 1987
  2. 3 generations backK962969 Medical Device Technologies, Inc.UltraMedical Device Technologies, Inc. · 1996
  3. 2 generations backK982085 Medical Device Technologies, Inc. Tru-Core Disposale Semi-Automatic…Medical Device Technologies, Inc. · 1998
  4. 1 generation backK982960 Meical Device Technologies, Inc. Tru-Core Disposable Automatic…Medical Device Technologies, Inc. · 1998 · Recalled
  5. This deviceK101832 Biopince Ultra Full Core Biopsy InstrumentMedical Device Technologies, Inc. · 2010
  6. Descendant · cites it directly · 0 of its ownK102756 Surecore Biopsy DeviceChest Innovations, Inc. · 2011

Most influential descendants

Showing 1 of 1 · See all
  • K102756Surecore Biopsy DeviceChest Innovations, Inc. · 2011 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−4K871390Bard Biopty Biopsy SystemC.R. Bard, Inc.1987—
−3K962969Medical Device Technologies, Inc.UltraMedical Device Technologies, Inc.1996—
−2K982085Medical Device Technologies, Inc. Tru-Core Disposale Semi-Automatic Biopdy…Medical Device Technologies, Inc.1998—
−1K982960Meical Device Technologies, Inc. Tru-Core Disposable Automatic Biopsy InstrumentMedical Device Technologies, Inc.19982
0 (this device)K101832Biopince Ultra Full Core Biopsy InstrumentMedical Device Technologies, Inc.2010—
+1K102756Surecore Biopsy DeviceChest Innovations, Inc.2011—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199110
199210
200420
200510

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201110
FIG. 1 — Lineage of K101832, 1987–2011Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KNW? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new KNW device

  1. #1 K260572 Marrow Marxmanscore 14.5 · 10 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (4)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K904987Vibronics Auto Core Biopsy Device (Acbd)
Summary page 1
…21 CFR 876.1075 Class 1I Legally marketed K904987 BioPince~h Full Core Biopsy Instrument devices to which the K982960 TruCore"'m Disposable Automatic Bi…
Vibronics19912
*K982960Meical Device Technologies, Inc. Tru-Core Disposable Automatic Biopsy Instrument
Summary page 1
…Class 1I Legally marketed K904987 BioPince~h Full Core Biopsy Instrument devices to which the K982960 TruCore"'m Disposable Automatic Biopsy Instrument device is substantially K042464 V-CoreTm Full Core Brea…
Medical Device Technologies, Inc.19982
*K042464V-Core Full Core Breast Biopsy Instrument
Summary page 1
…opsy Instrument devices to which the K982960 TruCore"'m Disposable Automatic Biopsy Instrument device is substantially K042464 V-CoreTm Full Core Breast Biopsy Instrument equivalent: K050 120 Easy CoreTm Biopsy System…
Medical Device Technologies, Inc.2004—
*K050120Easy Core Biopsy System II
Summary page 1
…tic Biopsy Instrument device is substantially K042464 V-CoreTm Full Core Breast Biopsy Instrument equivalent: K050 120 Easy CoreTm Biopsy System Description of the The BioPince Tm Ultra Full Core Biopsy Instrument is a…
Boston Scientific Corp2005—

Also cleared against K904987: 2 other devices →

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K102756Surecore Biopsy DeviceChest Innovations, Inc.20110

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 2 companies; a new generation was cleared every 9.5 years on median.
  • 3 of the 9 ancestors have a recall of any class.
  • Of its descendants, K102756 (Chest Innovations, Inc., 2011) has gone furthest, with 0 descendants of its own.
  • 2 other devices also cite its predicate K904987.

How does its category compare?

All KNW devices

KNW Instrument, Biopsy: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · KNW

12in 2025

2007: 62008: 42009: 62010: 32011: 102012: 72013: 32014: 82015: 102016: 92017: 82018: 72019: 52020: 82021: 92022: 82023: 72024: 52025: 122026 (partial year): 7
2007high 12 (2025) · low 3 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KNW

178in 2025

2007: 94 days median2008: 53 days median2009: 35 days median2010: 57 days median2011: 64 days median2012: 94 days median2013: 100 days median2014: 95 days median2015: 106 days median2016: 127 days median2017: 90 days median2018: 71 days median2019: 94 days median2020: 92 days median2021: 54 days median2022: 203 days median2023: 164 days median2024: 114 days median2025: 178 days median2026 (partial year): 29 days median
2007high 203 (2022) · low 35 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KNW

1in 2024

2007: 12008: 72009: 32010: 22011: 52012: 12013: 1, 1 Class I2014: 32016: 52017: 12019: 42021: 32022: 32023: 22024: 12026 (partial year): 4, 3 Class I
2007high 7 (2008) · low 0 (2015)2026

Class I (4 since 2007) Class II/III not classified

Adverse event reports per year · KNW

1,667in 2025

2007: 7662008: 3632009: 3512010: 1622011: 672012: 932013: 982014: 1932015: 5912016: 2972017: 7602018: 1,0122019: 4,1952020: 5,1202021: 1,0202022: 5352023: 9312024: 1,2832025: 1,667
2007high 5,120 (2020) · low 67 (2011)2025

MAUDE reports naming product code KNW, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20076941766
20084537363
20096353351
20103572162
20111064567
2012794193
201331001 (1)98
20148953193
2015101060591
201691275297
20178901760
201877101,012
201959444,195
202089205,120
202195431,020
202282033535
202371642931
2024511411,283
20251217801,667
20267294 (3)—

What is it indicated for?

The automatic BioPince Ultra Full Core Biopsy Instrument is intended for multiple percutaneous full-core sampling of soft tissue, tumors, or masses for histological analysis. Soft tissue sampling includes, but is not limited to, kidney, liver, breast, prostate and various soft tissue lesions.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K101832: Biopince Ultra Full Core Biopsy Instrument.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K101832

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026